1069: Mincheff M, Zoubak S, Makogonenko Y. Immune responses against PSMA after
gene-based vaccination for immunotherapy-A: results from immunizations in
animals. Cancer Gene Ther. 2006 Apr;13(4):436-44. PubMed PMID: 16276349.


1070: Mincheff M, Zoubak S, Altankova I, Tchakarov S, Pogribnyy P, Makogonenko Y,
Botev C, Meryman HT. Depletion of CD25+ cells from human T-cell enriched fraction
eliminates immunodominance during priming with dendritic cells genetically
modified to express a secreted protein. Cancer Gene Ther. 2005 Feb;12(2):185-97. 
PubMed PMID: 15375382.


1071: Mincheff M, Zoubak S, Altankova I, Tchakarov S, Makogonenko Y, Botev C,
Ignatova I, Dimitrov R, Madarzhieva K, Hammett M, Pomakov Y, Meryman H,
Lissitchkov T. Human dendritic cells genetically engineered to express
cytosolically retained fragment of prostate-specific membrane antigen prime
cytotoxic T-cell responses to multiple epitopes. Cancer Gene Ther. 2003
Dec;10(12):907-17. PubMed PMID: 14712317.


1072: Mincheff M, Altankova I, Zoubak S, Tchakarov S, Botev C, Petrov S, Krusteva
E, Kurteva G, Kurtev P, Dimitrov V, Ilieva M, Georgiev G, Lissitchkov T,
Chernozemski I, Meryman HT. In vivo transfection and/or cross-priming of
dendritic cells following DNA and adenoviral immunizations for immunotherapy of
cancer--changes in peripheral mononuclear subsets and intracellular IL-4 and
IFN-gamma lymphokine profile. Crit Rev Oncol Hematol. 2001
Jul-Aug;39(1-2):125-32. PubMed PMID: 11418309.


1073: Mincheff M, Tchakarov S, Zoubak S, Loukinov D, Botev C, Altankova I,
Georgiev G, Petrov S, Meryman HT. Naked DNA and adenoviral immunizations for
immunotherapy of prostate cancer: a phase I/II clinical trial. Eur Urol. 2000
Aug;38(2):208-17. PubMed PMID: 10895014.